Sun Pharma Stock Tumbles 6% Following Disappointing Q1 Earnings Report
Pharma giant Sun Pharma takes a beating as markets react to lackluster Q1 numbers.
Investors dump shares after earnings miss—because nothing says 'trust us' like a sudden 6% nosedive.
Another day, another earnings season casualty. At least the suits still get their bonuses.